跳至主要内容
临床试验/NCT06088693
NCT06088693已完成不适用

The Role of Electroacupuncture With Standard Therapy on Sperm Analysis and SOD Levels in Oligozoospermia.

Indonesia University2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2023年9月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
2
主要终点
SOD Plasma Semen

研究概览

简要总结

The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard therapy can affect oligozoospermia. 2. Electroacupuncture therapy and standard therapy can affect semen and spermatozoa plasma SOD levels.

Researchers will compare patient with standard therapy with patient with standard therapy with electroacupuncture.

详细描述

  1. Male subjects aged more than 25 years and less than 45 years.
  2. Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (<5 million spermatozoa/mL).
  3. Willing to take part in research and sign informed consent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The investigator blind the participant allocation

入排标准

年龄范围
25 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male 25 to 45 years old.
  • Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (<5 million spermatozoa/mL).
  • Willing to participate in research and sign informed consent.

排除标准

  • Emergency case patient / bleeding disorders
  • Have a tumor, scar tissue or infected wound in the area where the acupuncture needle will be inserted.
  • Alcoholic
  • Using a pacemaker (heart pacemaker).
  • Azoospermia
  • Varicocele

结局指标

主要结局

SOD Plasma Semen

时间窗: Before Treatment in day 1, After 30 days of treatment.

Superokside Dismutase in Plasma Semen

SOD Spermatozoa

时间窗: Before Treatment in day 1, After 30 days of treatment.

Superokside Dismutase in Spermatozoa

Sperm analysis

时间窗: Before Treatment in day 1, After 30 days of treatment.

Spermatozoa/mL

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Yunita

Medical Doctor

Indonesia University

研究点 (2)

Loading locations...

相似试验